Tag: Revision
Human medicines European Public Assessment Report (EPAR): Riprazo HCT , aliskiren / hydrochlorothiazide, Revision: 0, Withdrawn
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
